RNA-Based Cancer Vaccines Show Promising Progress by 2025
Senior VP of Operations at Seneca Therapeutics, Hung Trinh, has shared an update on the current progress and future perspectives of RNA-based cancer vaccines. These breakthrough treatments train the immune system to recognize and attack specific cancer cells. Recent clinical trials have shown impressive results, with one melanoma treatment reducing cancer recurrence by 44% when … Read more